Moreover, DLL1 downregulation caused a 2-fold reduction in the expression levels of CDC25A and SKP2 genes, which are often overexpressed in breast tumors and involved in BC pathogenesis [27,28]. This evidence concerns the gene DLL1 and breast cancer.